A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
This research study is looking into a new medication called GSK5764227. It's for people around the world who have advanced bowel (colorectal) or pancreatic cancer that has spread or can't be treated with surgery. These are cancers that affect the digestive system, also known as gastrointestinal cancers. The study wants to find out how well this new medicine works, if it's safe to use, and how the body processes it. Participants would have already received some other treatments for their cancer. This study is in the early stages of testing, aiming to understand the drug better before it can be widely used.
At a glance
What is this study about?
This study is a medical research project investigating a new medicine called GSK5764227. It's designed for people with advanced cancers of the digestive system, specifically bowel (colorectal) or pancreatic cancer. These are cancers that have either spread to other parts of the body (metastatic) or are too advanced to be removed by an operation.
The main goals of this study are to understand how safe the new medicine is, how well it works against the cancer, and how your body reacts to and processes the drug. This is important information to gather before a new medicine can be considered for wider use. All participants in this study would have already tried other treatments for their cancer.
This type of study is called a 'Phase 1' and 'Phase 2' trial. This means it's an early-stage study where researchers are still learning about a new treatment. They start by giving the drug to a small group of people to see if it's safe and to find the right dose, then gradually expand to a larger group to get a better idea of its effectiveness.
Key takeaways
- This study explores a new medicine for advanced bowel or pancreatic cancer.
- It's for patients who have already tried other treatments.
- The study aims to check the safety and how well the new medicine works.
- It's an early-stage study (Phases 1 and 2) to gather information.
- You can leave the study at any point if you choose to.
Who may be eligible?
To join this study, you need to be at least 18 years old and have advanced bowel (colorectal) or pancreatic cancer that cannot be removed by surgery. If you have bowel cancer, you must have tried one or two previous treatments that weren't successful. If you have pancreatic cancer, you must have tried one previous treatment that didn't work. The doctors will also need a sample of your cancer tissue, either from a recent biopsy or an older sample.
Your general health will be assessed to ensure you are well enough to take part, including having active cancer that can be measured. You should also be willing to use effective birth control if there's a chance of pregnancy. Before joining, you'll need to understand and agree to all the study requirements by signing a consent form.
There are also some reasons why you might not be able to join. For example, if you have another type of cancer that has recently progressed or needed active treatment (unless it's a very common skin cancer or a completely removed early-stage cancer). You also can't have had major surgery recently, typically within the last month.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have advanced bowel (colorectal) or pancreatic cancer that can't be removed by surgery?
- Have you already had at least one other cancer treatment?
- Are you able to provide a sample of your cancer tissue?
- Are you willing to use effective birth control if needed?
What does participation involve?
If you decide to take part in this study, the specific details of what's involved will be explained clearly by the study team. Generally, you would receive the study medicine, GSK5764227. This might be given on its own or alongside other standard cancer treatments. You would have regular appointments for check-ups, which include tests to see how you are responding to the treatment and to monitor your general health. These could involve blood tests, scans, and physical examinations.
The study would involve visits to the clinic for treatments and assessments. The exact number and frequency of visits will be outlined in the detailed study plan. You would be monitored closely for any side effects. After the main treatment period, there would likely be a follow-up phase to continue monitoring your health and the long-term effects of the treatment. The total duration of your participation would be fully explained before you join.
Potential risks and benefits
Locations (47)
- GSK Investigational SiteVerified postcodeLos Alamitos, United States· Recruiting
- GSK Investigational SiteVerified postcodeWhittier, United States· Recruiting
- GSK Investigational SiteVerified postcodeNew York, United States· Recruiting
- GSK Investigational SiteVerified postcodeDurham, United States· Recruiting
- GSK Investigational SiteVerified postcodeHouston, United States· Recruiting
- GSK Investigational SiteVerified postcodeSan Antonio, United States· Recruiting
- GSK Investigational SiteVerified postcodeWenatchee, United States· Recruiting
- GSK Investigational SiteVerified postcodeHeidelberg, Australia· Recruiting
- GSK Investigational SiteVerified postcodeMelbourne, Australia· Recruiting
- GSK Investigational SiteVerified postcodeBonheiden, Belgium· Recruiting
- GSK Investigational SiteVerified postcodeBrussels, Belgium· Recruiting
- GSK Investigational SiteVerified postcodeLeuven, Belgium· Recruiting
Common questions
What kind of cancers is this study for?
It's for advanced bowel (colorectal) or pancreatic cancer that can't be treated with surgery.
What is GSK5764227?
It's a new medicine being tested in this study. We are trying to understand how safe and effective it is.
Have patients received treatment before?
Yes, participants must have already tried at least one other treatment for their cancer.
What are 'Phase 1' and 'Phase 2' trials?
These are early-stage studies where researchers are learning about the safety and effectiveness of a new medicine.
Can I leave the study if I change my mind?
Yes, you can withdraw from the study at any time, for any reason, without affecting your care.
How to find out more
US GSK Clinical Trials Call Center
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.